Olympiad Research LP

STAMFORD, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 4, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$77.0M2026 Q3
Positions255
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.15.5%

Olympiad Research LP reported 255 positions worth $77.0M as of September 30, 2026 (13F filed November 4, 2026). Largest holding: AES (2.0%). Biggest move: exit XLF ($2.0M).

10 / 255 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AESAes$1.5M1.98%102,389——+0.3%
▸ 2 NATLNCR Atleos$1.5M1.97%33,542——+6.7%
▸ 3 CZRCaesars Entertainment$1.5M1.95%50,659——-0.9%
▸ 4 WTRGEssential Utilities$1.5M1.92%37,813——+15.3%
▸ 5 ROKURoku$1.1M1.43%7,225——+5.4%
▸ 6 OGNOrganon$1.0M1.34%75,358——+1.5%
▸ 7 SLABSilicon Laboratories$1.0M1.32%4,598——-0.1%
▸ 8 ACAArcosa$1.0M1.30%6,871——+2.1%
▸ 9 DDominion Energy$910.3K1.18%15,042——+12.0%
▸ 10 VALValaris$835.0K1.08%10,634——+1.3%

Pro Feature

The remaining 245 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Olympiad Research LP hold as of Q3 2026?

Olympiad Research LP reported 255 positions worth $77.0M in its Q3 2026 13F filing. Largest positions: AES (2.0%), NATL (2.0%), CZR (1.9%), WTRG (1.9%) and ROKU (1.4%).

What did Olympiad Research LP buy in Q3 2026?

New positions: CZR, ACA, BAC, SCHW and CVS (197 in all). Added to: GS, BPOP, TDOC, AMP and SLAB (29 in all).

What did Olympiad Research LP sell in Q3 2026?

Reduced: UNF, MU, AVT, SMCI and AGL (15 in all). Sold out entirely: XLF, QRVO, NWE, WED and PEN (80 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.